Congenital Sucrase-isomaltase Deficiency
📧 Sign up to get email alerts when something new happens for Congenital Sucrase-isomaltase Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-05-25FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) from QOL Medical, LLC.
-
FDA approval · 2014-12-02FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical, LLC. This action pertains to the regulatory stat…
-
FDA approval · 2013-05-28FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
FDA approved SUCRAID (sacrosidase) through a supplemental application submitted by QOL Medical, LLC.
-
FDA approval · 2011-06-15FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) submitted by QOL Medical, LLC.
-
FDA approval · 2010-12-09FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-11-20FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical, LLC.
-
FDA approval · 2008-02-20FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical LLC. The approval adds or modifies labeling for t…